HEPATOID ADENOCARCINOMA OF STOMACH
Clinical trials for HEPATOID ADENOCARCINOMA OF STOMACH explained in plain language.
Never miss a new study
Get alerted when new HEPATOID ADENOCARCINOMA OF STOMACH trials appear
Sign up with your email to follow new studies for HEPATOID ADENOCARCINOMA OF STOMACH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo tackles rare stomach cancer before and after surgery
Disease control Recruiting nowThis study tests a combination of chemotherapy drugs and an immunotherapy drug (sintilimab) given before and after surgery for a rare type of stomach cancer called HER2-negative hepatoid adenocarcinoma. The goal is to see if this approach can shrink tumors and improve outcomes. A…
Matched conditions: HEPATOID ADENOCARCINOMA OF STOMACH
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated May 26, 2026 11:45 UTC
-
New drug cocktail shows promise for rare stomach cancer
Disease control Recruiting nowThis study tests a combination of three drugs (RC48, chemotherapy, and an immunotherapy) given before and after surgery for a rare stomach cancer called hepatoid adenocarcinoma. The goal is to see if this approach can completely eliminate the tumor before surgery and prevent it f…
Matched conditions: HEPATOID ADENOCARCINOMA OF STOMACH
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated May 08, 2026 12:03 UTC